A surprising discovery from Rockefeller University suggests that a common amino acid could play a powerful role in protecting against cancer and viral infections. Scientists found that low arginine levels interfere with the immune system's ability to recognize dangerous cells, while increasing arginine intake reduced colon cancer tumors and improved viral infection outcomes in mice. The researchers discovered that when arginine becomes scarce, cells struggle to produce enough of a crucial immune system protein known as MHC-1, which acts as a warning system, helping immune cells identify potential dangers such as cancerous changes or viral infections. Supplying a moderate amount of arginine, comparable to the quantity available in a couple of over-the-counter supplement tablets, could help restore production of this important protein. The study suggests that upping arginine intake could prove beneficial in treating both cancer and viral infections. Further research in humans is needed to determine whether the benefits observed in mice translate into effective treatments for people.